DWM
EW icon

Darwin Wealth Management’s Edwards Lifesciences EW Stock Holding History

Darwin Wealth Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.8K Hold
42
– – ﹤0.01% 466
2026
Q1 		$3.36K Hold
42
– – ﹤0.01% 447
2025
Q4 		$3.58K Hold
42
– – ﹤0.01% 483
2025
Q3 		$3.27K Hold
42
– – ﹤0.01% 469
2025
Q2 		$3.28K Hold
42
– – ﹤0.01% 448
2025
Q1 		$3.11K Hold
42
– – ﹤0.01% 482
2024
Q4 		$3.11K Buy
+42
New +$2.94K ﹤0.01% 482
2020
Q2 		– Sell
-66
Closed -$4K – 334
2020
Q1 		$4K Buy
+66
New +$4.76K ﹤0.01% 613

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Darwin Wealth Management's EW Position: Q2 2026 in Review

Darwin Wealth Management held its Edwards Lifesciences (EW) position steady in Q2 2026 at 42 shares worth $3.8K. The position accounts for ﹤0.01% of the portfolio, ranked #466.

Darwin Wealth Management first reported a position in EW in Q1 2020 and has held it in 8 quarters since. The position peaked at $4K in Q1 2020. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Darwin Wealth Management held 42 shares of Edwards Lifesciences worth $3.8K as of Q2 2026.
  • Darwin Wealth Management left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up ﹤0.01% of Darwin Wealth Management's portfolio in Q2 2026, its #466 holding.
  • Darwin Wealth Management first reported a position in Edwards Lifesciences in Q1 2020 and has held it in 8 quarters since.
  • Darwin Wealth Management's Edwards Lifesciences position peaked at $4K in Q1 2020.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Darwin Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.